Kate Therapeutics is a next-generation gene therapy company focused on developing innovative treatments for genetic skeletal muscle and heart diseases, including Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD)
Kate Therapeutics is a next-generation gene therapy company focused on developing innovative treatments for genetic skeletal muscle and heart diseases, including Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
The top three firms on F4's Biotech & Life Sciences investor list.